Barclays has lowered its price target for International Flavors & Fragrances (IFF) to $88.00, triggering speculation among shareholders. Despite underperforming compared to competitors, the company secured multiple new shares purchases by Oak Thistle LLC, Covea Finance, Czech National Bank, and S.E.E.D Planning Group LLC. IFF's new product, Enviva® DUO, is developed to boost poultry welfare. While the stock received an increased rating to buy at Argus, IFF emerged among Billionaire Carl Icahn’s top stock picks, suggesting potential growth.
\n\nThe company managed to report strong quarterly financial results despite their shares decreasing on various occasions. IFF is launching significant initiatives, such as a new state-of-the-art Center for Innovation in Shanghai and an AI-powered Chinese fragrance program targeting the $97B market. However, the company faces government-unit penalties providing some turbulence.
\n\nA proposed $2.85 billion deal to sell the pharma unit to France's Roquette is underway. IFF's resilience is reflected in its shares, which show a 54% gain when purchased a year ago. Recovering from a brief leadership period under Frank Clyburn, IFF appointed a new Chief Financial Officer, Michael DeVeau. Despite challenges, IFF remains among Oppenheimer's top stock picks for the next 12 months.
International Flavors Fragrances IFF News Analytics from Wed, 14 Feb 2024 15:39:11 GMT to Sat, 18 Jan 2025 16:12:14 GMT - Rating 6 - Innovation 8 - Information 8 - Rumor 3
